TenckhoffHACurtisFK. Experience with maintenance peritoneal dialysis in the home. Am Soc Artif Intern Organs1970; 16: 90–96.
3.
BuoncristianiUMazzottaGCarobiCGallaiVCozzariMDi PaoloB. Control of uremic neuropathy by equilibrium peritoneal dialysis. Int J Artificial Organs1984; 7: 97–100.
4.
HamedLMWinwardKEGlaserJSSchatzNJ. Optic neuropathy in uremia. Am J Ophthalmol1989; 108: 30–35.
5.
BabALPopovichRPChristopherTGScribnerBH. The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs1971; 17: 81–88.
6.
BabALAhmadSBergstromJScribnerBH. The middle molecule hypothesis in perspective. Am J Kidney Dis1981; 1: 46–52.
7.
HughesJRRoxeDMdel GrecoF. Electrophysiological studies on uremic patients: comparison of peritoneal dialysis and hemodialysis. Clin Electroencephalogr1980; 11: 72–82.
8.
AltmanPDhaneshaUHamonCCunninghamJBlairJMarshF. Disturbance of cerebral function by aluminum in hemodialysis patients without overt aluminum toxicity. Lancet1989; 1: 7–11.
9.
FuchsCBrasheMPascenKNordbeckHQuellhorstE. Aluminum-Besimmung im serum mit flammenloser atomabsorption. Clin Chim Acta1979; 52: 71–80.
10.
SegreGV. Amino terminal radioimmunoassay for human parathyroid hormone. FrameBPottsJTJr (eds). Clinical Disorders of Bone and Mineral Metabolism. Amsterdam: Excerpta Medica1983: 14pp.
11.
HintzeJL. Number Cruncher Statistical System (4.21). 865 East 400 North, Kaysville, Utah 84037.
LewisEGDustmanREBeckEC. Visual and somatosensory evoked potential characteristics of patients undergoing hemodialysis and kidney transplantation. Electroencephalogr Clin Neurophysiol1978; 44: 223–231.
15.
LowitzschKGohringUHeckingEKohlerH. Refractory period sensory conduction velocity and visual evoked potentials before and after hemodialysis. J Neurol Neurosurg Psychiat1981; 44: 121–128.
16.
RossiniPMPirchioMTrevisoMGambiDDi PaoloBAlbertazziA. Checkerboard reversal pattern and flash VEPs in dialysed and nondialysed subjects. Electroencephalogr Clin Neurophysiol1981; 52: 435–444.
17.
CohenSNSyndulkoKReverBKrautJCoburnJTourtellotteWW. Visual evoked potentials and long latency event-related potentials in chronic renal failure. Neurology1983; 33: 1219–1222.
18.
KubaMPeregrinFVitFHanusovaIErbenJ. Pattern reversal visual evoked potentials in patients with chronic renal insufficiency. Electroencephalogr Clin Neurophysiol1983; 56: 438–442.
19.
WalserHKrissACunninghamKHallidayAMJonesSJTaubeD. Amultimodal evoked potential assessment of uremia. In: NodarRHBarberC (eds). Evoked Potentials II. The Second International Evoked Potential Symposium. Boston: Butterworth; 1984; 80: 643–649.
20.
RussellPSekulerRRoxeDMessersmithRMulvannyP. Contrast sensitivity of hemodialysis patients. Met Ped Sys Ophthalmol1984; 7: 201–205.
21.
KlingerM. EEG observations in uremia. Electroencephalogr Clin Neurophysiol1954; 6: 519.
22.
HymanPRKooiKA. Visual evoked cortical responses in renal insufficiency. Univ Mich Med Centr J1969; 35: 177–179.
23.
FendickMG. Clinical use of the VECP. ReineckRD (ed). Ophthalmology Annual 1989. New York: Raven Press; 1989: 169 pp.
24.
HolidayAMBarrettGBlumhardtLDKrissA. In: LehmannDCallawayE (eds). Human Evoked Potentials: Applications and Problems. New York: Plenum Press; 1979: 135 pp.
25.
CampbellFWRobsonJG. Application of Fourier analysis to the visibility of gratings. J Physiol (Lon)1968; 197: 551–556.
26.
Bodis-WollnerIGhilardiMFMylinLH. The importance of stimulus selection in VEP practice: the clinical relevance of visual physiology. In: CraccoRQBodis-WollnerI (eds). Evoked Potentials: Frontiers of Clincal Neuroscience. New York: Alan R. Liss; 1986; 11 pp.
27.
HallidayAM. The value of half-field stimulation in clinical visual evoked potential testing. In: MorocuttiCRizzoPA (eds). Evoked Potentials. Neurophysiological and Clinical Aspects. Elsevier Science Publ BV; 1985: 293–313.
28.
Bodis-WollnerIBarrisMMylinLHJuleszBKropfLW. Binocular stimulation reveals cortical components of the human VEP. Electroencephalogr Clin Neurophysiol1981; 52: 298–385.
29.
Bodis-WollnerIMylinLFrkovicS. The topography of the N70 component of the visual evoked potential in humans. In: MaurerK (ed). Topographic Brain Mapping of EEG and Evoked Potentials. Berlin-Heidelberg: Springer-Verlag; 1989: 397 pp.
30.
GhilardiMFSartucciFBrannanJB. N70 and P100 can be independently affected in multiple sclerosis. Electroencephalogr Clin Neurophysiol1991; 80: 1–7.
31.
ParkerDMSalzenEALishmanJR. Visual evoked responses elicited by the onset and offset of sinusoidal gratings: latency, waveform, and topographical characteristics. Invest Ophthalmol Visual Sci1982; 22: 675–680.
32.
PrevicFT. The neurophysiological significance of the N1 and P1 components of the visual evoked potential. Clin Vision Sci1988; 3: 195–202.
33.
JeffreysDAAxfordJG. Source locations of pattern specific components of human visual evoked potential: I component of striate cortical origin; II component of extrastriate cortical origin. Exp Brain Res1970; 16: 1–40.
34.
BreceljJPrevecTS. Study of foveal and peripheral visual responses evoked by pattern-reversal stimulation. In: NodarRHBarbervC (eds), Evoked Potentials II. The Second International Evoked Potential Symposium. Boston: Butterworth; 1984; 31: 280–286.
35.
LesevreNJosephJP. Modifications of the pattern-evoked potential (PEP) in relation to the stimulated part of the visual field clues for the most probable origin of each component. Electroencephalogr Clin Neurophysiol1979; 47: 183–203.
36.
CrapperDRQuittkatSKrishnanSS. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy and experimental aluminum encephalopathy, Acta Neuropath (Berl)1986; 50:19–24.
37.
PerlDPGajdusekDCGarrutoRM. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinson dementia of Guam. Science1982; 217: 1053–1055.
